Electrocore ECOR 深 滬
已收盤 12-19 16:00:00 美东时间
4.60
+0.180
+4.07%
華盛通- 最 高4.81
- 今 開4.57
- 成交量 5.31万股
- 最 低 4.47
- 昨 收 4.42
- 總市值 3488.36万
- 52周最高 19.49
- 市盈率 靜 --
- 換手率 0.70%
- 52周最低 4.16
- 委 比 -54.80%
- 總股本 758.34万
- 歷史最高 303.75
- 量 比 1.04
- 振 幅 7.69%
- 歷史最低 2.925
- 每 手 1
- 風險率 4.48%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen
electroCore, Inc. announced the publication of a peer-reviewed paper demonstrating that its TAC-STIM non-invasive vagal nerve stimulation device enhances mood, task performance, and learning in high-stress military training environments. The study, involving 70 active-duty Air Force trainees, found statistically significant reductions in stress and improvements in energy, skill, and objective performance metrics among tVNS users. Results highligh...
12-02 13:00
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
electroCore, Inc. announced that its management will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York on November 20, 2025. The event will include one-on-one meetings with investors, which can be scheduled through Canaccord Genuity sales representatives or by contacting electroCore's Investor Relations at ecor@fnkir.com.
11-10 21:05
electroCore Sees FY2025 Sales $31.500M-$32.500M vs $30.749M Est
electroCore (NASDAQ:ECOR) sees FY2025 sales of $31.500 million-$32.500 million vs $30.749 million analyst estimate.
11-06 08:00
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
Ecora Resources Announces Strategic Partnership in Santo Domingo Project
The latest update is out from Ecora Resources ( ($GB:ECOR) ). Ecora Resources h...
10-14 18:12
Electrocore Finalizes Stock Sale to Settle Legal Fees
Electrocore ( ($ECOR) ) has issued an announcement. On September 30, 2025, Elec...
10-04 04:58
gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms
ElectroCore's gammaCore device shows promise in reducing symptoms of mild traumatic brain injury (mTBI), according to a study published in *Frontiers in Neurology*. The research involving 102 patients found significant improvements in 16 out of 22 symptom categories, with 34% of participants reporting meaningful relief in at least half their symptoms. Notably, benefits were observed regardless of the time since injury, and no adverse device-relat...
09-30 12:00
electroCore Announces Its GammaCore Sapphire Non-Invasive Vagus Nerve Stimulation Device Has Been Included In Long-Term Reimbursement Policy By Belgium's National Institute For Health And Disability Insurance
electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCore™ Sapphire (nVNS) has been included in a long-term reimbursement policy launched by the National Institute for Health and Disability Insurance (RIZIV / INAMI) in Belgium.
09-29 20:12
electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium
electroCore's gammaCore Sapphire (nVNS) has been included in Belgium's long-term reimbursement policy by RIZIV/INAMI, effective October 1, 2025, covering cluster headache treatment. The decision, supported by clinical evidence of efficacy and cost-effectiveness, improves access for Belgian patients. Silvert Medical, electroCore's partner, played a key role in securing this reimbursement.
09-29 12:00
electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards
electroCore's Truvaga™ Plus device, a handheld vagus nerve stimulator, has been awarded "Best Relaxation Gadget" in Esquire’s 2025 Sleep Awards. The device, recognized for its ability to reduce stress and promote sleep in just two minutes, was selected after rigorous testing. As a leader in bioelectronic medicine, electroCore emphasizes its commitment to enhancing health through innovative, non-invasive solutions. The Truvaga Plus also offers a r...
09-22 12:00
